DRA-10922 - USA (Washington, DC) - Kidney Cancer Research Program Service - Deadline September 28,2026

(1) Vendor needs to provide kidney cancer research program service to the government authority located in Washington, DC. • Vision is to conquer kidney cancer through collaboration and discovery. • The mission of the fy26 is to promote rigorous, innovative, high–impact research in kidney cancer for the benefit of service members, their families, veterans and the american public.• Encourage innovative ideas with high impact.• Identify new targets.• Develop pharmacological, immunological, genetic, microbiome or other interventions.• Optimize prognostic or predictive markers to assist with therapeutic decision–making.• Repurpose existing and currently approved interventions.• Integrate bench research with bedside care and promote translational research.• Invest in early–career kidney cancer physicians – next generation.• Facilitate multi–site collaborative clinical research development and clinical trials.• Foster collaborations that cross translational, disciplinary and institutional boundaries.